Latest Publications

Share:

Time Flies! Cosmetic Manufacturing Facilities are Due for FDA Registration Renewal

Manufacturers and processors of U.S.-distributed cosmetic products must renew their facility registration for the first time by July 1, 2026. To assist with the biennial registration requirement, the Food and Drug...more

FDA Announces Enforcement Discretion for Certain “No Artificial Colors” Claims

The U.S. Food and Drug Administration (FDA) announced several coordinated updates on February 5, 2026, that collectively signal a major shift in the agency’s oversight of “no artificial colors” claims on foods intended for...more

New Federal Nutrition Guidelines Signal Continued Scrutiny of Ultra-Processed Foods

The U.S. Department of Health and Human Services (HHS) and the U.S. Department of Agriculture (USDA) recently released the highly anticipated 2025-2030 Dietary Guidelines for Americans, which the Trump Administration...more

FDA Explains Its Mandatory Cosmetics Recall Authority, Adhering Closely to 2022 Statutory Language

The U.S. Food and Drug Administration (FDA, or the Agency) published a draft guidance explaining its mandatory recall authority for cosmetic products on December 18, 2025 (90 FR 59129). Entitled “Questions and Answers...more

Reforming GRAS: Digesting the Proposed “Better Food Disclosure Act” (S. 3122)

Senator Roger Marshall (R-KS) introduced much-anticipated legislation this month that seeks to reform the process by which “generally recognized as safe” (GRAS) substances are assessed by the U.S. Food and Drug Administration...more

Ninth Circuit Upends USDA’s Bioengineered Food Disclosure Requirements

In Natural Grocers v. Rollins, the U.S. Court of Appeals for the Ninth Circuit significantly upended certain parts of the U.S. Department of Agriculture’s (USDA) National Bioengineered Food Disclosure Standard (BE Rule). ...more

DOJ Creates New Enforcement & Affirmative Litigation Branch Within Civil Division

On Thursday September 25, the U.S. Department of Justice (DOJ) announced the creation of a new Enforcement & Affirmative Litigation Branch within the Civil Division. According to the DOJ press release, DOJ’s affirmative...more

FDA’s Proposed Ranking Tool Gives Public Opinion a Seat at the Food Safety Table

With food policy remaining a top priority for the Trump Administration, the U.S. Food and Drug Administration (FDA), acting under Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., has swiftly advanced a number...more

FDA’s Catch-Up Plan on Cosmetics Faces Likely Regulatory Delays with Change in Administrations

The U.S. Food and Drug Administration (FDA) has been playing catch-up on three long-delayed proposed rules required under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA): •Standardized test methods to detect...more

FDA Updates Final Guidance on Cosmetic Facility Registration and Product Listing: Wiley

The Food and Drug Administration (FDA) recently issued a Notice announcing the availability of an updated final guidance for the industry entitled “Registration and Listing of Cosmetic Product Facilities and Products.” The...more

Time’s Up! Cosmetic Facilities Must Comply With FDA’s New Registration Requirements by July 1

The July 1, 2024 deadline is fast approaching for cosmetic product manufacturers to comply with new registration and listing requirements under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). Passage of the...more

The End of an Era: FDA Announces Disposition Plans for COVID-19 Related Guidance Documents

The COVID-19 pandemic presented the U.S. Food and Drug Administration (FDA or Agency) with a monumental task of shifting its operations and the way it approached the regulation of critical drugs, medical devices, and biologic...more

FDA Proposes New Exemptions From IND Regulations for Certain Drug Use Clinical Studies of Food, Dietary Supplements, and Cosmetic...

In what could be a game-changer to the dietary supplement and food industry, the U.S. Food and Drug Administration (FDA or Agency) is proposing to amend the investigational new drug (IND) regulations to exempt clinical...more

Be Prepared: FDA Signals Transition Countdown for Medical Devices Marketed Under COVID-Era Enforcement Policies, EUAs

On October 17, 2022, the U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) released the list of guidance documents proposed for publication in fiscal year 2023. While it is unclear if...more

[Podcast] Cellular Agriculture and the Evolving Legal/Regulatory Landscape: A Conversation with Ahmed Khan [Audio]

On this episode of “Food for Thought and Thoughts on Food,” Ann Begley and Amaru Sanchez join to discuss regulatory and commercialization challenges facing novel foods today. The pair interview Ahmed Khan, Founder and Editor...more

FDA’s Remote Regulatory Assessments Q&A Draft Guidance Document Explains the Regulated Industry’s New Virtual Reality

The U.S. Food and Drug Administration (FDA or Agency) recently announced the availability of a new draft guidance titled “Conducting Remote Regulatory Assessments: Questions and Answers” (RRA Draft Guidance). Remote...more

FDA CARES a Lot About Drug Reporting: Takeaways From Draft Guidance for New Annual 510(j)(3) Reporting Requirement for Released...

Recently, the U.S. Food and Drug Administration (FDA) announced the availability of a draft guidance titled “Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3) of the FD&C Act” (Draft Guidance)....more

Selling Cell-Based Proteins

On September 3, 2021, the United States Department of Agriculture (USDA) Food Safety and Inspection Service (FSIS) published an Advance Notice of Proposed Rulemaking (ANPR) on the Labeling of Meat or Poultry Products...more

The White House Launches Supply Chain Initiatives on Essential Items

On June 8, 2021, the White House released its 250-page “Building Resilient Supply Chains, Revitalizing American Manufacturing, and Fostering Broad-Based Growth” report (the Report) and an accompanying fact sheet entitled:...more

OTC Drug User Facility Fees – Don’t Miss the Changes!

On January 4, 2021, FDA unexpectedly withdrew the notice entitled Fee Rates Under the Over the Counter Monograph User Fee Program for Fiscal Year 2021 stating that it had been ordered to cease further collection efforts...more

Labeling of Foods Comprised of or Containing Cultured Seafood Cells: FDA Requests Public Comment

The U.S. Food and Drug Administration (FDA) published a request for information in the Federal Register in connection with labeling of foods made with cultured seafood cells. FDA will use the information received to decide...more

Full Speed Ahead – FDA’s Digital Health Center of Excellence to Host Listening Sessions

On September 22, 2020, the U.S. Food and Drug Administration (FDA) announced the establishment of the Digital Health Center of Excellence (DHCE) within FDA’s Center for Devices and Radiological Health (CDRH). Bakul Patel will...more

26 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide